• Team
    ▼
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    ▼
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Crowley Law, LLC

Crowley Law New Frontier

Call: 844-256-5891
  • Team
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers
  • Team
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers

Conducting Clinical Trials During the Pandemic

9.14.20

The COVID-19 pandemic has disrupted just about every national and global industry, and drug companies are certainly no exception.
One of the primary concerns for the pharmaceutical industry is the impact on clinical trials of drugs, medical devices, and biological products. These trials are an important method of proving the safety and efficacy of proposed new treatments. And with current travel restrictions and site closures severely impacting the supply chain, efficient collection of clinical trial results has suffered.

FDA Guidelines

In an effort to prevent further disruption of important data collected through clinical trials, the FDA along with its Office of Good Clinical Practice (“OGCP”) has issued new guidelines for clinical trial sponsors, including home-based electronic data capture via telemedicine and telephone interviews.

Such dramatic changes to the trial process come with valid concerns about how to ensure patient safety while simultaneously ensuring adequate and accurate data collection. And for pharmaceutical companies, there’s also the issue of protecting the integrity of their clinical trial processes while controlling the already high cost of such trials.

What Does This Mean for Your Business?

In view of the unprecedented nature of the COVID-19 pandemic and the diverse needs and goals of different life science companies, there appears to be no one-size-fits-all solution to the FDA’s guidelines for home-based data collection. Each clinical trial, site and subject must be evaluated on a case-by-case basis to determine what amendments and deviations from the approved pre-COVID clinical trial protocol are appropriate.

According to the FDA, some amendments and deviations to a standard protocol must be reported as part of the clinical trial, but reporting is not necessary for all protocol deviations. For example, if a trial site is now mandating COVID-19 screening, the screening itself does not need to be reported as an amendment unless any data collected from the COVID-19 screening is specifically included in a new research objective.
However, amendments made in an effort to limit COVID-19 exposure to trial subjects must be reported in amendments to applications for investigational device exemptions and investigational new drug applications. But such amendments do not have to be approved by the Institutional Review Board.

That’s an important element because of the additional cost and time involved in obtaining such approvals. And in clinical trial management, additional time and delay frequently means additional costs and logistical problems.
Depending on the location and type of clinical trials being conducted and the nature of the disease, medication, or device being studied, the impact of COVID-19 control methods will vary widely. Some of the most obvious and challenging impacts will likely include an inability to fulfill certain required procedures, such as the method of administering the product being studied or performing testing entirely in a laboratory setting.

If you are concerned about how the FDA’s new guidance on clinical trials will impact your business, the skilled legal team at the Law Office of Philip P. Crowley LLC can help. Our experienced, highly-knowledgeable IP, science, tech, and drug company attorneys have been serving pharmaceutical industry clients throughout New York and New Jersey for more than 30 years.
Our team has a deep understanding of the rights, goals, and interests of this industry, and work tirelessly to ensure our clients are protected in the most efficient and cost-effective manner possible.

Contact the Law Office of Philip P. Crowley LLC today at (844) 256-5891 today for a free and confidential consultation.
You’re Passionate About Your Ideas.
So Are We.
We provide full-service representation to emerging tech and life-sciences startups from garage to marketplace.
crowleylawllc.com

P.S. I’m excited to announce my newest entrepreneur client – my daughter Jennifer!
She’s in the sort of chemical engineering/chemical processing space – otherwise known as small-batch granola manufacturing. She has some amazing fresh products including one of my favorites that I haven’t seen anywhere else – Rosemary & Olive Oil Savory granola. You’ll be amazed by the flavor you find in a product that hasn’t been sitting in warehouses and on shelves for months.
See her “shop” at https://www.etsy.com/shop/SweetieBeeBakes
Please give them a try and let me know whether you agree with me that her products are “addictively delicious.”

Primary Sidebar

Depend on us to keep you informed with our monthly newsletter and invites to informative webinars and seminars.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Crowley Law LLC, 89 Headquarters Plaza, Morristown, NJ, 07960, https://www.crowleylawllc.com/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Privacy Disclaimer

Footer

Crowley Law LLC
Business & Technology Attorneys


Phone: 844-256-5891
Email: [email protected]
New Jersey Office | New York Office
About | Services | Resources & Events | Contact Us

Awards Disclaimer

Copyright © 2023 by Crowley Law LLC.
All rights reserved. Terms of Use / Privacy Policy | Sitemap
Attorney Advertising. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Website by New Frontier

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Cookie settingsACCEPTREJECT Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT